1,721,036 research outputs found
Supplementary_Table_6._PYY – Supplemental material for Gastrointestinal Hormones Manipulation to Counteract Metabolic Syndrome Using Duodenal Targeted Embolization
No full textSupplemental material, Supplementary_Table_6._PYY for Gastrointestinal Hormones Manipulation to Counteract Metabolic Syndrome Using Duodenal Targeted Embolization by Raoul Pop, Seong-Ho Kong, Allan Langlois, Francesco Marchegiani, Eran Shlomovitz, András Legnèr, William Bietiger, Michel Pinget, Rémy Beaujeux, Didier Mutter, Jacques Marescaux and Michele Diana in Surgical Innovation</p
Supplementary_Table_5._GLP1 – Supplemental material for Gastrointestinal Hormones Manipulation to Counteract Metabolic Syndrome Using Duodenal Targeted Embolization
No full textSupplemental material, Supplementary_Table_5._GLP1 for Gastrointestinal Hormones Manipulation to Counteract Metabolic Syndrome Using Duodenal Targeted Embolization by Raoul Pop, Seong-Ho Kong, Allan Langlois, Francesco Marchegiani, Eran Shlomovitz, András Legnèr, William Bietiger, Michel Pinget, Rémy Beaujeux, Didier Mutter, Jacques Marescaux and Michele Diana in Surgical Innovation</p
Supplementary_Table_7._RNA_SGLT-1 – Supplemental material for Gastrointestinal Hormones Manipulation to Counteract Metabolic Syndrome Using Duodenal Targeted Embolization
No full textSupplemental material, Supplementary_Table_7._RNA_SGLT-1 for Gastrointestinal Hormones Manipulation to Counteract Metabolic Syndrome Using Duodenal Targeted Embolization by Raoul Pop, Seong-Ho Kong, Allan Langlois, Francesco Marchegiani, Eran Shlomovitz, András Legnèr, William Bietiger, Michel Pinget, Rémy Beaujeux, Didier Mutter, Jacques Marescaux and Michele Diana in Surgical Innovation</p
Supplementary_Table_4._GIP – Supplemental material for Gastrointestinal Hormones Manipulation to Counteract Metabolic Syndrome Using Duodenal Targeted Embolization
No full textSupplemental material, Supplementary_Table_4._GIP for Gastrointestinal Hormones Manipulation to Counteract Metabolic Syndrome Using Duodenal Targeted Embolization by Raoul Pop, Seong-Ho Kong, Allan Langlois, Francesco Marchegiani, Eran Shlomovitz, András Legnèr, William Bietiger, Michel Pinget, Rémy Beaujeux, Didier Mutter, Jacques Marescaux and Michele Diana in Surgical Innovation</p
Supplementary_Table_8._RNA_GLUT-2 – Supplemental material for Gastrointestinal Hormones Manipulation to Counteract Metabolic Syndrome Using Duodenal Targeted Embolization
No full textSupplemental material, Supplementary_Table_8._RNA_GLUT-2 for Gastrointestinal Hormones Manipulation to Counteract Metabolic Syndrome Using Duodenal Targeted Embolization by Raoul Pop, Seong-Ho Kong, Allan Langlois, Francesco Marchegiani, Eran Shlomovitz, András Legnèr, William Bietiger, Michel Pinget, Rémy Beaujeux, Didier Mutter, Jacques Marescaux and Michele Diana in Surgical Innovation</p
Supplementary_Table_2._Insulin – Supplemental material for Gastrointestinal Hormones Manipulation to Counteract Metabolic Syndrome Using Duodenal Targeted Embolization
No full textSupplemental material, Supplementary_Table_2._Insulin for Gastrointestinal Hormones Manipulation to Counteract Metabolic Syndrome Using Duodenal Targeted Embolization by Raoul Pop, Seong-Ho Kong, Allan Langlois, Francesco Marchegiani, Eran Shlomovitz, András Legnèr, William Bietiger, Michel Pinget, Rémy Beaujeux, Didier Mutter, Jacques Marescaux and Michele Diana in Surgical Innovation</p
Supplementary_Table_1._Ghrelin – Supplemental material for Gastrointestinal Hormones Manipulation to Counteract Metabolic Syndrome Using Duodenal Targeted Embolization
No full textSupplemental material, Supplementary_Table_1._Ghrelin for Gastrointestinal Hormones Manipulation to Counteract Metabolic Syndrome Using Duodenal Targeted Embolization by Raoul Pop, Seong-Ho Kong, Allan Langlois, Francesco Marchegiani, Eran Shlomovitz, András Legnèr, William Bietiger, Michel Pinget, Rémy Beaujeux, Didier Mutter, Jacques Marescaux and Michele Diana in Surgical Innovation</p
Supplementary_Table_3._Leptin – Supplemental material for Gastrointestinal Hormones Manipulation to Counteract Metabolic Syndrome Using Duodenal Targeted Embolization
No full textSupplemental material, Supplementary_Table_3._Leptin for Gastrointestinal Hormones Manipulation to Counteract Metabolic Syndrome Using Duodenal Targeted Embolization by Raoul Pop, Seong-Ho Kong, Allan Langlois, Francesco Marchegiani, Eran Shlomovitz, András Legnèr, William Bietiger, Michel Pinget, Rémy Beaujeux, Didier Mutter, Jacques Marescaux and Michele Diana in Surgical Innovation</p
Going Beyond Counting First Authors in Author Co-citation Analysis
Full text linkThe present study examines one of the fundamental aspects of author co-citation analysis (ACA) - the way co-citation
counts are defined. Co-citation counting provides the data on which all subsequent statistical analyses and mappings
are based, and we compare ACA results based on two different types of co-citation counting - the traditional type that
only counts the first one among a cited work's authors on the one hand and a non-traditional type that takes into
account the first 5 authors of a cited work on the other hand. Results indicate that the picture produced through this non-traditional author co-citation counting contains more coherent author groups and is therefore considerably clearer. However, this picture represents fewer specialties in the research field being studied than that produced through the traditional first-author co-citation counting when the same number of top-ranked authors is selected and analyzed. Reasons for these effects are discussed
- …
